Scholar Rock's Phase 3 SAPPHIRE Study Of Apitegromab In SMA Meets Primary Goal; Stock Surges
Scholar Rock Holding Corporation (SRRK), a late-stage biopharmaceutical company, Monday said its Phase 3 SAPPHIRE study evaluating ...
Utah has the last conventional uranium mill in the country. What does it do?
The White Mesa Mill, which hadn’t processed much uranium over the last 20 years, now plans to be open for the foreseeable ...
Scholar Rock’s stock soars more than 200% on positive trial of treatment for spinal muscular atrophy
Scholar Rock Holdings Corp.’s stock soared more than 200% early Monday, after the clinical-stage biotech said a late-stage trial of a treatment for spinal muscular atrophy met its main goal. The Phase ...
Scholar Rock Holding's Spinal Muscular Atrophy Drug Apitegromab Meets Primary Study Endpoint
Scholar Rock Holding said that its treatment for spinal muscular atrophy met primary endpoint targets in a phase 3 clinical trial. The late-stage biopharmaceutical company said Monday that Apitegromab ...